Dr. José Luis Adrio holds a Ph.D. in Pharmacy from the University of Santiago de Compostela and an Organization & Management of Technological Innovation program from the Polytechnic University of Madrid. He has been a postdoctoral researcher at the Department of Biology at MIT, Cambridge, EE.UU and has developed his profesional activity in several biotech companies such as Antibióticos de León, Puleva Biotech, Neuron Biopharma, Neol Bio and Evolgene. Currently he is the R&D director at ADL Biopharma.
Expert in the development of microbial biotechnology processes from laboratory to pilot scale, molecular biology techniques and metabolic engineering. He has also deep knowledge about development programs of microbial strains as well as management of R&D projects.